logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11661405 B1

PDFFull Text
Date of Patent:
May. 30, 2023

Filed:

Apr. 05, 2021

Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions

Applicant:

Anavex Life Sciences Corp., New York, NY (US);

Inventors:

Linda Sharon Daintree, Leeds, GB;

Daniel Mark Ledger, Bradford, GB;

Lucy Anne Leonard, Bradford, GB;

Peter York, Bradford, GB;

Alani Selvey, New York, NY (US);

Assignee:

ANAVEX LIFE SCIENCES CORP., New York, NY (US);

Attorney:

Polsinelli PC

Primary Examiner:

Valerie Rodriguez-Garcia

Int. Cl.
CPC ...
C07D 307/14 (2006.01); B01D 9/00 (2006.01); B01D 11/04 (2006.01); A61P 25/28 (2006.01); A61K 31/341 (2006.01);
U.S. Cl.
CPC ...
C07D 307/14 (2013.01); A61P 25/28 (2018.01); B01D 9/005 (2013.01); B01D 11/0403 (2013.01); B01D 11/0411 (2013.01); A61K 31/341 (2013.01);
Abstract

Polymorphic forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73) and a metabolite of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73) are disclosed and characterized. Compositions and method for treatment of Alzheimer's disease that includes the polymorphic forms and metabolite of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73).

Find Patent Forward Citations

Daintree, Linda. (2023). Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions (U.S. Patent No. 11661405). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11661405

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…